# P2X7R deficiency alleviates cardiac senescence by enhancing mitophagy via the HuR/TRIM26/NR4A1 axis

**Authors:** Yixin Zhou, Xin Zhong, Zhijie Mao, Yunxuan Chen, Jincheng Xing, Jiaxu Shen, Wenli Zhang, Ji Zhang, Jiaxuan Mei, Zhentong Yang, Zhuoqun Wang, Bozhi Ye, Jiahui Lin, Yonghua Wang, Zhouqing Huang

PMC · DOI: 10.1002/ctm2.70621 · Clinical and Translational Medicine · 2026-02-26

## TL;DR

P2X7R deficiency improves heart function in aged mice by boosting mitophagy through a specific molecular pathway involving HuR, TRIM26, and NR4A1.

## Contribution

This study identifies a novel signaling axis (HuR/TRIM26/NR4A1) through which P2X7R regulates cardiac senescence and mitophagy.

## Key findings

- P2X7R deficiency alleviates cardiac senescence and improves mitophagy in aged mice.
- P2X7R promotes HuR nucleocytoplasmic shuttling, increasing TRIM26 stability and suppressing NR4A1 expression.
- TRIM26-mediated NR4A1 ubiquitination suppresses mitophagy and accelerates cardiac aging.

## Abstract

Ageing is a significant risk factor for pathophysiological alterations in the heart, but the intrinsic mechanisms by which these occur have yet to be fully elucidated. Purinergic 2×7 receptor (P2X7R) is important for the pathogenesis of numerous cardiovascular diseases; nevertheless, its function in the process of cardiac ageing remains uncertain.

This study utilised P2X7R knockout (P2X7R−/−) mice. An ageing model was established by either maintaining mice until they reached 20 months of age or performing chronic subcutaneous injection of D‐galactose (D‐gal). Recombinant adeno‐associated virus serotype 9 (AAV9) was employed to achieve cardiac‐specific overexpression of P2X7R and nuclear receptor subfamily 4 group A member 1 (NR4A1). Cardiac function and histopathological changes in cardiac tissues were evaluated. Transcriptome sequencing was further applied to elucidate the potential mechanisms of P2X7R in cardiac senescence.

Our result show that serum levels of P2X7R increase with advancing age in humans and that P2X7R expression is upregulated during cardiac senescence in mice. P2X7R deficiency alleviates ageing‐related cardiac dysfunction, senescence phenotypes and impaired mitophagy. Cardiomyocyte‐specific overexpression of P2X7R with AAV9 exacerbates the myocardial dysfunction, senescence phenotype and mitophagy disruption induced by D‐gal. Mechanistically, P2X7R promotes human antigen R (HuR) nucleocytoplasmic shuttling in ageing hearts, thereby increasing the mRNA stability of tripartite motif containing 26 (TRIM26) and the expression of the E3 ubiquitin ligase TRIM26. TRIM26 subsequently mediates NR4A1 ubiquitination, leading to its proteasomal degradation, which subsequently suppresses mitophagy in cardiomyocytes and ultimately accelerates cardiac ageing.

Our findings provide valuable insights into the role of P2X7R in cardiac ageing and identify the HuR/TRIM26/NR4A1 axis as a key signalling pathway through which P2X7R regulates cardiac ageing.

P2X7R regulates the nucleoplasmic translocation of HuR, thereby enhancing the stability of the E3 ubiquitin ligase TRIM26. TRIM26 directly binds to NR4A1 and promotes its ubiquitination, thereby suppressing mitophagy and increasing reactive oxygen species (ROS) production. Consequently, this triggers inflammasome activation and enhances the secretion of senescence‐associated secretory phenotype (SASP) factors, ultimately contributing to cardiac dysfunction in cardiac senescence.

## Linked entities

- **Genes:** P2rx7 (purinergic receptor P2X, ligand-gated ion channel, 7) [NCBI Gene 18439], TRIM26 (tripartite motif containing 26) [NCBI Gene 7726], NR4A1 (nuclear receptor subfamily 4 group A member 1) [NCBI Gene 3164], ELAVL1 (ELAV like RNA binding protein 1) [NCBI Gene 1994]
- **Chemicals:** D-galactose (PubChem CID 206)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Trim55 (tripartite motif-containing 55) [NCBI Gene 381485] {aka D830041C10Rik, MuRF-2, Murf2, Rnf29}, Trim26 (tripartite motif-containing 26) [NCBI Gene 22670] {aka Zfp173, Zfp1736}, Trim30a (tripartite motif-containing 30A) [NCBI Gene 20128] {aka Rpt-1, Rpt1, Trim30}, Elavl1 (ELAV like RNA binding protein 1) [NCBI Gene 15568] {aka 2410055N02Rik, HUR, Hua}, Mul1 (mitochondrial ubiquitin ligase activator of NFKB 1) [NCBI Gene 68350] {aka 0610009K11Rik, Gide, Tnrip-1}, Cdkn1a (cyclin dependent kinase inhibitor 1A) [NCBI Gene 12575] {aka CAP20, CDKI, CIP1, Cdkn1, P21, SDI1}, Glb1 (galactosidase, beta 1) [NCBI Gene 12091] {aka Bge, Bgl, Bgl-e, Bgl-s, Bgl-t, Bgs}, P2rx7 (purinergic receptor P2X, ligand-gated ion channel, 7) [NCBI Gene 18439] {aka P2X(7), P2X7R}, Gapdh (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 14433] {aka Gapd}, Pink1 (PTEN induced putative kinase 1) [NCBI Gene 68943] {aka 1190006F07Rik, BRPK, mFLJ00387}, Qsox1 (quiescin Q6 sulfhydryl oxidase 1) [NCBI Gene 104009] {aka 1300003H02Rik, QSOX, Qscn6, SOx, b2b2673Clo}, Trim71 (tripartite motif-containing 71) [NCBI Gene 636931] {aka 2610206G21Rik, Gm1127, Lin41, lin-41, mLin41, mlin-41}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, Sox2 (SRY (sex determining region Y)-box 2) [NCBI Gene 20674] {aka Sox-2, lcc, ysb}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, Prkn (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 50873] {aka Park2}, Nr4a1 (nuclear receptor subfamily 4, group A, member 1) [NCBI Gene 15370] {aka GFRP1, Gfrp, Hbr-1, Hbr1, Hmr, N10}, NLRP3 (NLR family pyrin domain containing 3) [NCBI Gene 114548] {aka AGTAVPRL, AII, AVP, C1orf7, CIAS1, CLR1.1}, Trim34a (tripartite motif-containing 34A) [NCBI Gene 94094] {aka Trim34, Trim34-1}, Tomm20 (translocase of outer mitochondrial membrane 20) [NCBI Gene 67952] {aka 1810060K07Rik, Gm19268, MAS20, MOM19, TOM20, mKIAA0016}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, Agt (angiotensinogen) [NCBI Gene 11606] {aka AngI, AngII, Aogen, Serpina8}, Trp53-ps (transformation related protein 53, pseudogene) [NCBI Gene 22060], P2RX7 (purinergic receptor P2X 7) [NCBI Gene 5027] {aka P2X7}, Trim16 (tripartite motif-containing 16) [NCBI Gene 94092] {aka 9130006M08Rik, EBBP}, Gsk3b (glycogen synthase kinase 3 beta) [NCBI Gene 56637] {aka 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3}, Il18 (interleukin 18) [NCBI Gene 16173] {aka Igif, Il-18}, H3c7 (H3 clustered histone 7) [NCBI Gene 260423] {aka H3.2-221, H3c13, H3c14, H3c15, H3c2, H3c3}, Acsm3 (acyl-CoA synthetase medium-chain family member 3) [NCBI Gene 20216] {aka Sa, Sah}, Sqstm1 (sequestosome 1) [NCBI Gene 18412] {aka A170, OSF-6, Osi, STAP, STONE14, p62}, Cdkn2a (cyclin dependent kinase inhibitor 2A) [NCBI Gene 12578] {aka ARF-INK4a, Arf, INK4a-ARF, Ink4a/Arf, MTS1, Pctr1}, Trim5 (tripartite motif-containing 5) [NCBI Gene 667823] {aka EG667823, Gm8833}, Trim13 (tripartite motif-containing 13) [NCBI Gene 66597] {aka 3110001L12Rik, CAR, LEU5, RNF77, Rfp2}, Map1lc3b (microtubule-associated protein 1 light chain 3 beta) [NCBI Gene 67443] {aka 1010001C15Rik, Atg8, LC3b, MAP1A/MAP1B, Map1lc3}, Trim2 (tripartite motif-containing 2) [NCBI Gene 80890] {aka mKIAA0517, narf}, Trim41 (tripartite motif-containing 41) [NCBI Gene 211007] {aka RINCK}, Nppa (natriuretic peptide type A) [NCBI Gene 230899] {aka ANP, Anf, CDD, Pnd}, Tnnt2 (troponin T2, cardiac) [NCBI Gene 21956] {aka Tnt, cTnT}, Trim65 (tripartite motif-containing 65) [NCBI Gene 338364] {aka 4732463G12Rik}, Traf2 (TNF receptor-associated factor 2) [NCBI Gene 22030], Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Wwp2 (WW domain containing E3 ubiquitin protein ligase 2) [NCBI Gene 66894] {aka 1300010O06Rik, AIP2}
- **Diseases:** cardiac alterations (MESH:D006338), cardiac abnormalities (MESH:D018376), overdose (MESH:D062787), glioblastoma (MESH:D005909), heart failure (MESH:D006333), breast cancer (MESH:D001943), cardiac ageing (MESH:D006331), cardiac hypertrophy (MESH:D006332), Cardiac remodelling (MESH:D020257), hypertrophy (MESH:D006984), atrial fibrillation (MESH:D001281), myocardial infarction (MESH:D009203), vascular remodelling (MESH:D066253), cardiovascular diseases (MESH:D002318), insulin deficiency (MESH:D007333), atherosclerosis (MESH:D050197), hypertension (MESH:D006973), diabetic cardiomyopathy (MESH:D058065), arrhythmias (MESH:D001145), cancer (MESH:D009369), cardiac fibrosis (MESH:D005355), cardiac inflammation (MESH:D007249), mitochondrial (MESH:D028361)
- **Chemicals:** CHX (MESH:D003513), eosin (MESH:D004801), calcium (MESH:D002118), chloroquine (MESH:D002738), ROS (MESH:D017382), DMSO (MESH:D004121), citrate (MESH:D019343), carbon dioxide (MESH:D002245), ATP (MESH:D000255), lipids (MESH:D008055), celastrol (MESH:C050414), MDA (MESH:D008315), carbohydrate (MESH:D002241), H&amp;E (MESH:D006371), DIM8 (-), 3-methyladenine (MESH:C025946), haematoxylin (MESH:D006416), SA (MESH:D000077145), actinomycin D (MESH:D003609), bafilomycin A1 (MESH:C040929), Sirius (MESH:C433343), D-gal (MESH:D005690), water (MESH:D014867), STZ (MESH:D013311), MG132 (MESH:C072553), isoflurane (MESH:D007530), testosterone (MESH:D013739), A438079 (MESH:C523668), fat (MESH:D005223)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** C-23 C
- **Cell lines:** HL-1 — Mus musculus (Mouse), Transformed cell line (CVCL_0303), C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), AAV9 — Homo sapiens (Human), Transformed cell line (CVCL_9804)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12940804/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12940804/full.md

## References

48 references — full list in the complete paper: https://tomesphere.com/paper/PMC12940804/full.md

---
Source: https://tomesphere.com/paper/PMC12940804